{"schema_version":"1","generated_at":"2026-11-11T09:45:33.171Z","data_as_of":"2026-11-09","url":"https://www.findmykol.com/kol/giannis-mountzios","json_url":"https://www.findmykol.com/kol/giannis-mountzios/profile.json","record_kind":"full","profile_kind":"research","person":{"slug":"giannis-mountzios","name":"Giannis Mountzios","credential":"PhD","title":"Director, 4th Internal Medicine – Oncology Clinic, Henry Dunant Hospital (listed as \"Director: Mountzios Ioannis\")","specialty":"Medicine","therapeutic_area":"Lung","therapeutic_areas":["Lung","Oncology"],"institution":"Henry Dunant Hospital Center","institution_url":"https://www.findmykol.com/institution/henry-dunant-hospital-center","country":{"name":"Greece","code":"GR","status":"provisional"},"register":{"country":"GR"}},"identifiers":{"orcid":"0000-0002-7780-7836","openalex":"A5044610238"},"summary":"Giannis Mountzios is Director, 4th Internal Medicine – Oncology Clinic, Henry Dunant Hospital (listed as \"Director: Mountzios Ioannis\") at Henry Dunant Hospital Center. OpenAlex indexes 261 publications with 7,220 citations (h-index 41); ClinicalTrials.gov lists 1 registered study with this person as an investigator.","overview":{"text":"Giannis Mountzios is Director, 4th Internal Medicine – Oncology Clinic, Henry Dunant Hospital (listed as \"Director: Mountzios Ioannis\") at Henry Dunant Hospital Center, Athens. The public record shows 261 publications with 7,220 citations (h-index 41), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. It also documents an investigator role on 1 registered clinical trials.","bullets":["Most recent indexed publication: 2026 · Cancer research communications","Top research focus: Lung Cancer Treatments and Mutations","1 registered trials on ClinicalTrials.gov"],"generated_at":"2026-11-10"},"focus":{"indications":[{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":4},{"label":"Carcinoma, Small Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Small Cell Lung Carcinoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Bladder / Urothelial Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Osteoporosis","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Pancreatic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1}],"research_topics":["Lung Cancer Treatments and Mutations","Lung Cancer Diagnosis and Treatment","Lung Cancer Research Studies","Cancer Genomics and Diagnostics","Cancer Immunotherapy and Biomarkers"],"works_with":{"total":1,"shown":1,"withheld":0,"rows":[{"name":"SystImmune Inc.","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":261,"cited_by_count":7220,"h_index":41,"i10_index":107,"pubmed_count":26,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07625644","title":"BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"SystImmune Inc.","source_url":"https://clinicaltrials.gov/study/NCT07625644","trial_url":"https://www.findmykol.com/trial/NCT07625644"}],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":41,"years":{"first":2007,"last":2026},"societies":["AACR","ASCO","ESMO","IASLC"],"shown":3,"withheld":38,"rows":[{"title":"A phase 3 study of sacituzumab govitecan in patients with previously treated extensive-stage small cell lung cancer.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.tps8137","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.tps8137","status":"verified"},{"title":"Association patterns among patient-reported adverse events in advanced NSCLC: A post-hoc analysis of the CLIMEDIN randomized controlled trial.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e23271","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e23271","status":"verified"},{"title":"Comprehensive genomic profiling of patients with cancer of unknown primary (CUP).","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e15188","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e15188","status":"verified"}],"source":"congress"},"publications":{"total":26,"shown":5,"withheld":21,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.","year":2026,"journal":"Cancer research communications","types":["Journal Article","Clinical Trial, Phase III"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42447505/","status":"verified"},{"title":"Artificial Intelligence in ALK-Rearranged NSCLC: Forecasting Response and Resistance.","year":2026,"journal":"Cancers","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41899575/","status":"verified"},{"title":"Neoadjuvant, Adjuvant and Perioperative Treatment in Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Actionable Genomic Alterations: Current Landscape and Future Perspectives.","year":2026,"journal":"Cancers","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41681965/","status":"verified"},{"title":"SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non-Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group Study.","year":2026,"journal":"JCO clinical cancer informatics","types":["Journal Article","Randomized Controlled Trial","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41632937/","status":"verified"},{"title":"Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece-The TRINITY Study.","year":2025,"journal":"Cancers","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41463271/","status":"verified"}],"source":"publications"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"other","url":"https://loop.frontiersin.org/people/634644","status":"provisional"}]},"mentions":{"total":1,"shown":1,"rows":[{"url":"https://www.dunant.gr/en/news/press-releases/press-releases-2025/anosotherapia-karkinou-pnevmona/","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"PhD in Thoracic Oncology, University of Athens School of Medicine (2010)","source_url":"https://www.esmo.org/about-esmo/profiles/giannis-mountzios","status":"provisional","collected_at":"2026-11-09"},{"value":"Board-certified in Medical Oncology (2009)","source_url":"https://www.esmo.org/about-esmo/profiles/giannis-mountzios","status":"provisional","collected_at":"2026-11-09"}]},"roles":{"total":3,"shown":3,"rows":[{"value":"Member, ESMO Young Oncologists Committee (2012-2014)","source_url":"https://www.esmo.org/Profiles/Giannis-Mountzios","status":"provisional","collected_at":"2026-11-09"},{"value":"Member, Board of Directors, Hellenic Society for Medical Oncology (HESMO)","source_url":"https://www.esmo.org/about-esmo/profiles/giannis-mountzios","status":"provisional","collected_at":"2026-11-09"},{"value":"Chair, Young Medical Oncologists Committee, Hellenic Society for Medical Oncology (HESMO) (former; years not stated)","source_url":"https://www.esmo.org/about-esmo/profiles/giannis-mountzios","status":"provisional","collected_at":"2026-11-09"}]},"awards":{"total":3,"shown":3,"rows":[{"value":"Fellowship, American Society of Clinical Oncology (ASCO) (year and award name not found)","source_url":"https://www.esmo.org/about-esmo/profiles/giannis-mountzios","status":"provisional","collected_at":"2026-11-09"},{"value":"Fellowship, European Society for Medical Oncology (ESMO) (year and award name not found)","source_url":"https://www.esmo.org/about-esmo/profiles/giannis-mountzios","status":"provisional","collected_at":"2026-11-09"},{"value":"Fellowship, Hellenic Society for Medical Oncology (HESMO) (year not found)","source_url":"https://www.esmo.org/about-esmo/profiles/giannis-mountzios","status":"provisional","collected_at":"2026-11-09"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Consultant Medical Oncologist, Department of Medical Oncology, Air Force General Hospital, Athens (older ESMO profile listing; conflicts with current Henry Dunant role)","source_url":"https://www.esmo.org/about-esmo/profiles/giannis-mountzios","status":"provisional","collected_at":"2026-11-09"},{"value":"Scientific Co-ordinator, Lung Cancer Working Group, Hellenic Co-operative Oncology Group (HeCOG)","source_url":"https://esmo.org/about-esmo/profiles/Giannis-Mountzios","status":"provisional","collected_at":"2026-11-09"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Author of ESMO course and congress commentary pieces on OncoDaily (for example \"Giannis Mountzios: ESMO Advanced Course on Early-Stage NSCLC\")","source_url":"https://oncodaily.com/voices/giannis-mountzios-460102","status":"provisional","collected_at":"2026-11-09"}]}},"similar":[{"name":"Ignacio Wistuba","slug":"ignacio-wistuba","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ignacio-wistuba","json_url":"https://www.findmykol.com/kol/ignacio-wistuba/profile.json"},{"name":"Pasi Janne","slug":"pasi-janne","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/pasi-janne","json_url":"https://www.findmykol.com/kol/pasi-janne/profile.json"},{"name":"Julie Brahmer","slug":"julie-brahmer","institution":"Johns Hopkins University School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/julie-brahmer","json_url":"https://www.findmykol.com/kol/julie-brahmer/profile.json"},{"name":"Enriqueta Felip","slug":"enriqueta-felip","institution":"Vall d'Hebron Institute of Oncology (VHIO)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/enriqueta-felip","json_url":"https://www.findmykol.com/kol/enriqueta-felip/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":38,"publications":21}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-09"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-09"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-09"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-09"}},"methodology_url":"https://www.findmykol.com/about#methodology"}